Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating

Upworthy

Published

In This Article: Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated coverage of Novavax Inc. (NASDAQ:NVAX) with a Sell rating and a $6 price target. A closeup of a vial of the biotechnology company's vaccines. The firm…

Full Article